Brind.

Investment Comparison Highlights Biodesix vs. McKesson Corporation

1 report, 1 independent Updated Sat 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

An independent report compared Biodesix and McKesson Corporation as potential investments. The analysis noted that McKesson has higher revenue and earnings per share than Biodesix. Regarding ownership, McKesson attracts 85.1% institutional investors, while Biodesix has 21.0% institutional ownership and 23.2% insider ownership.

From dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The report found that Biodesix trades at a lower price-to-earnings ratio than McKesson, suggesting it was the more affordable of the two stocks at the time of writing. Furthermore, Biodesix has a beta of 0.6, indicating its share price is 40% less volatile than the S&P 500.

From dailypolitical.com

Who's involved

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • McKesson CorporationSpeculative

    Market sentiment regarding McKesson Corporation could be affected by the unfavorable contrast presented in the investment analysis.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped